Daehan New Pharm rises 3.68% amid African Swine Fever (ASF) theme surge

On the 30th, the African Swine Fever (ASF) theme rose by 3.42% compared to the previous day, showing strength, while Daehan New Pharm, a related stock attracting attention, surged by 3.68% compared to the previous day. Daehan New Pharm is known as a company that manufactures and sells pharmaceuticals for humans and animals.

[Graph] Major stock price changes in the African Swine Fever (ASF) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Daehan New Pharm's quant financial score is 44.36 points, with higher stability and profitability scores than the average of other stocks related to African Swine Fever (ASF), ranking 10th within the theme. This indicates that Daehan New Pharm's ability to respond to changes in the domestic and international economic environment and its efficient profit-generating capability are better compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.